Karbownik M, Lewinski A, Modrzejewska H, Greger J
Department of Thyroidology, University School of Medicine at Lódź, Poland.
Endocr Regul. 1994 Dec;28(4):199-203.
We examined the effect of vasoactive intestinal polypeptide (VIP) on thymidine kinase (TK) activity in the tissue of rat thyroid lobes incubated in vitro. Additionally, thyrotropin, epidermal growth factor, as well as atropine and carbachol were studied. It was shown that: 1. thyrotropin and epidermal growth factor did not essentially affect TK activity; 2. the effect of VIP was dose dependent: the high concentrations of peptide (10(-7) M and 10(-5) M) suppressed, while the lower concentrations (10(-15)M, 10(-13)M, 10(-11)M and 10(-9) M)-enhanced TK activity; 3. atropine tended to increase TK activity, however, that rise did not attain statistical significance; 4. VIP, when used together with atropine, decreased TK activity when compared with the activity in question after exposure to atropine alone; 5. carbachol suppressed TK activity; 6. the joint action of carbachol and VIP did not significantly change the activity of the examined enzyme.
我们研究了血管活性肠肽(VIP)对体外培养的大鼠甲状腺叶组织中胸苷激酶(TK)活性的影响。此外,还研究了促甲状腺激素、表皮生长因子以及阿托品和卡巴胆碱的作用。结果表明:1. 促甲状腺激素和表皮生长因子对TK活性基本无影响;2. VIP的作用呈剂量依赖性:高浓度肽(10⁻⁷M和10⁻⁵M)抑制TK活性,而低浓度(10⁻¹⁵M、10⁻¹³M、10⁻¹¹M和10⁻⁹M)增强TK活性;3. 阿托品有增加TK活性的趋势,但该升高未达到统计学显著性;4. VIP与阿托品联合使用时,与单独使用阿托品后的TK活性相比,TK活性降低;5. 卡巴胆碱抑制TK活性;6. 卡巴胆碱和VIP的联合作用未显著改变所检测酶的活性。